QuidelOrtho Corporation
QDEL · NASDAQ
12/31/2024 | 12/29/2024 | 12/31/2023 | 1/1/2023 | |
|---|---|---|---|---|
| Revenue | $2,783 | – | $2,998 | – |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $1,496 | – | $1,503 | – |
| Gross Profit | $1,287 | – | $1,494 | – |
| % Margin | 46.2% | – | 49.8% | – |
| R&D Expenses | $219 | – | $247 | – |
| G&A Expenses | $0 | – | $748 | – |
| SG&A Expenses | $767 | – | $763 | – |
| Sales & Mktg Exp. | $0 | – | $15 | – |
| Other Operating Expenses | $2,262 | – | $345 | – |
| Operating Expenses | $3,247 | – | $1,355 | – |
| Operating Income | -$1,961 | – | $139 | – |
| % Margin | -70.5% | – | 4.6% | – |
| Other Income/Exp. Net | -$171 | – | -$168 | – |
| Pre-Tax Income | -$2,132 | – | -$29 | – |
| Tax Expense | -$80 | – | -$19 | – |
| Net Income | -$2,052 | – | -$10 | – |
| % Margin | -73.7% | – | -0.3% | – |
| EPS | -30.54 | – | -0.15 | – |
| % Growth | – | – | – | – |
| EPS Diluted | -30.54 | – | -0.15 | – |
| Weighted Avg Shares Out | 67 | – | 67 | – |
| Weighted Avg Shares Out Dil | 67 | – | 67 | – |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | – | $2 | – |
| Interest Expense | $188 | – | $179 | – |
| Depreciation & Amortization | $453 | – | $457 | – |
| EBITDA | -$1,490 | – | $607 | – |
| % Margin | -53.5% | – | 20.2% | – |